Proteomics

Dataset Information

0

Human A549 CD38, part 2 - Decreased NAD Activates STAT3 and Integrin Pathways to Drive Epithelial-Mesenchymal Transition


ABSTRACT: SILAC-Labeled proteomic analysis of A549 CD38 human lung cancer cell

INSTRUMENT(S): Q Exactive

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Lung

SUBMITTER: weixuan wang  

LAB HEAD: haiteng deng

PROVIDER: PXD007123 | Pride | 2018-07-11

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
MS161743_A-1.pep.xml Pepxml
MS161743_A-1.prot.xml Xml
MS161743_A10_170115074502.raw Raw
MS161743_A11_170115100155.raw Raw
MS161743_A12_170115121847.raw Raw
Items per page:
1 - 5 of 28
altmetric image

Publications

Decreased NAD Activates STAT3 and Integrin Pathways to Drive Epithelial-Mesenchymal Transition.

Wang Weixuan W   Hu Yadong Y   Yang Changmei C   Zhu Songbiao S   Wang Xiaofei X   Zhang Zhenyu Z   Deng Haiteng H  

Molecular & cellular proteomics : MCP 20180706 10


Nicotinamide adenine dinucleotide (NAD) plays an essential role in all aspects of human life. NAD levels decrease as humans age, and supplementation with NAD precursors plays a protective role against aging and associated disease. Less is known about the effects of decreased NAD on cellular processes, which is the basis for understanding the relationship between cellular NAD levels and aging-associated disease. In the present study, cellular NAD levels were decreased by overexpression of CD38, a  ...[more]

Similar Datasets

2018-07-10 | PXD007122 | Pride
2018-09-24 | PXD010284 | Pride
2018-09-24 | PXD010286 | Pride
2018-07-11 | PXD009917 | Pride
2024-10-17 | PXD051121 | Pride
2022-03-14 | PXD029320 | Pride
2022-02-23 | PXD012119 | Pride
2018-01-09 | PXD006877 | Pride
2020-12-02 | PXD022299 | Pride
2023-11-15 | PXD024159 | Pride